Overcoming xenotransplantation barriers through gene editing and immunomodulation

1. Merrill, J. P., Murray, J. E., Harrison, J. H. & Guild, W. R. Successful homotransplantation of the human kidney between identical twins. JAMA https://doi.org/10.1001/jama.1956.02960390027008 (1956).

   Article  Google Scholar 

2. Starzl, T. E. et al. Homotransplantation of the liver in humans. Surg. Gynecol. Obstet. 117, 659–676 (1963).

   Google Scholar 

3. Hardy, J. D., Eraslan, S. & Webb, W. R. Transplantation of the lung. Ann. Surg. https://doi.org/10.1097/00000658-196409000-00008 (1964).

   Article  Google Scholar 

4. Gondolesi, G. E. History of clinical intestinal transplantation. Hum. Immunol. https://doi.org/10.1016/j.humimm.2024.110788 (2024).

   Article  Google Scholar 

5. Klintmalm, G. B. The history of organ transplantation in the baylor health care system. Proc. (Bayl. Univ. Med. Cent.) https://doi.org/10.1080/08998280.2004.11927954 (2004).

   Article  Google Scholar 

6. Barnard, C. N. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S. Afr. Med. J. 41, 1271–1274 (1967). This is the first report of transplantation of a human heart into a man, marking a historic milestone in cardiac surgery and organ transplantation.

   Google Scholar 

7. Siems, C., Huddleston, S. & John, R. A brief history of xenotransplantation. Ann. Thorac. Surg. https://doi.org/10.1016/j.athoracsur.2022.01.005 (2022).

   Article  Google Scholar 

8. Lewis, A. Organ donation in the US and Europe: the supply vs demand imbalance. Transplant. Rev. 35, 100585 (2021).

   Google Scholar 

9. Health Resources & Services Administration. Organ donation statistics. HRSA https://www.organdonor.gov/learn/organ-donation-statistics?utm_source=chatgpt.com (2025).

10. Girlanda, R. Deceased organ donation for transplantation: challenges and opportunities. World J. Transpl. https://doi.org/10.5500/wjt.v6.i3.451 (2016).

    Article  Google Scholar 

11. Combes, A. Mechanical circulatory support for end-stage heart failure. Metabolism https://doi.org/10.1016/j.metabol.2017.01.009 (2017).

    Article  Google Scholar 

12. Taylor, D. A., Elgalad, A. & Sampaio, L. C. What will it take before a bioengineered heart will be implanted in patients? Curr. Opin. Organ Transpl. https://doi.org/10.1097/MOT.0000000000000583 (2018).

    Article  Google Scholar 

13. Saleh, T., Caciolli, L., Giobbe, G. G. & De Coppi, P. Ex vivo organ engineering using decellularized tissue scaffolds. Nat. Rev. Bioeng. https://doi.org/10.1038/s44222-025-00322-5 (2025).

    Article  Google Scholar 

14. Binet, J. P., Carpentier, A., Langlois, J., Duran, C. & Colvez, P. Implantation of heterogenic valves in the treatment of aortic cardiopathies. C. R. Acad. Hebd. Seances Acad. Sci. D 261, 5733–5734 (1965).

    Google Scholar 

15. Manji, R. A., Lee, W. & Cooper, D. K. C. Xenograft bioprosthetic heart valves: past, present and future. Int. J. Surg. https://doi.org/10.1016/j.ijsu.2015.07.009 (2015).

    Article  Google Scholar 

16. Tzavellas, N. P. et al. Decellularized scaffolds and heart valve treatment: present techniques, long-standing hurdles and the challenging future. Biomater. Adv. https://doi.org/10.1016/j.bioadv.2025.214367 (2025).

    Article  Google Scholar 

17. Hardy, J. D. et al. Heart transplantation in man. Developmental studies and report of a case. JAMA 188, 1132–1140 (1964).

    Google Scholar 

18. Reemtsma, K. et al. Renal heterotransplantation in man. Ann. Surg. 160, 384–410 (1964).

    Google Scholar 

19. Starzl, T. E. et al. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 2, 752–776 (1964).

    Google Scholar 

20. Butler, D. FDA warns on primate xenotransplants. Nature https://doi.org/10.1038/19144 (1999).

    Article  Google Scholar 

21. Griffith, B. P. et al. Genetically modified porcine-to-human cardiac xenotransplantation. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2201422 (2022). This is the first report of transplanting a genetically engineered pig heart into a man, demonstrating a major advancement in xenotransplantation research.

    Article  Google Scholar 

22. Griffith, B. P. et al. Transplantation of a genetically modified porcine heart into a live human. Nat. Med. https://doi.org/10.1038/s41591-024-03429-1 (2025).

    Article  Google Scholar 

23. Montgomery, R. A. et al. Results of two cases of pig-to-human kidney xenotransplantation. N. Engl. J. Med. 386, 1889–1898 (2022). This is the first report of transplanting a genetically engineered pig heart into a brain-dead deceased patient, providing crucial insights into the feasibility and safety of xenografts.

    Google Scholar 

24. Kawai, T. et al. Xenotransplantation of a porcine kidney for end-stage kidney disease. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2412747 (2025).

    Article  Google Scholar 

25. Tao, K. S. et al. Gene-modified pig-to-human liver xenotransplantation. Nature https://doi.org/10.1038/s41586-025-08799-1 (2025).

    Article  Google Scholar 

26. Cooley, D. A., Hallman, G. L., Bloodwell, R. D., Nora, J. J. & Leachman, R. D. Human heart transplantation. experience with twelve cases. Am. J. Cardiol. 22, 804–810 (1968).

    Google Scholar 

27. Starzl, T. E. et al. Baboon-to-human liver transplantation. Lancet 341, 65–71 (1993).

    Google Scholar 

28. Peterson, L. et al. Physiological basis for xenotransplantation from genetically modified pigs to humans. Physiol. Rev. 104, 1409–1459 (2024).

    Google Scholar 

29. Eisenson, D. et al. Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs. Nat. Commun. 15, 3361 (2024).

    Google Scholar 

30. Cooper, D. K. C., Ekser, B. & Tector, A. J. Immunobiological barriers to xenotransplantation. Int. J. Surg. 23, 211–216 (2015).

    Google Scholar 

31. Zhang, J. et al. Potential antigens involved in delayed xenograft rejection in a Ggta1/Cmah dko pig-to-monkey model. Sci. Rep. 7, 10024 (2017).

    Google Scholar 

32. Habibabady, Z. et al. Antibody-mediated rejection in xenotransplantation: can it be prevented or reversed? Xenotransplantation 30, e12816 (2023).

    Google Scholar 

33. Eyestone, W. et al. in Clinical Xenotransplantation: Pathways and Progress in the Transplantation of Organs and Tissues Between Species (eds David, K. C. C. & Guerard, B.) 121–140 (Springer, 2020).

34. Deschamps, J. Y., Roux, F. A., Sai, P. & Gouin, E. History of xenotransplantation. Xenotransplantation 12, 91–109 (2005).

    Google Scholar 

35. Taniguchi, S. Ratites (ostrich, emu) as potential heart donors for humans: immunologic, anatomic, and physiologic considerations. Xenotransplantation 3, 252–259 (1996).

    Google Scholar 

36. Dai, Y. et al. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20, 251–255 (2002).

    Google Scholar 

37. Lagutina, I., Lazzari, G. & Galli, C. Birth of cloned pigs from zona-free nuclear transfer blastocysts developed in vitro before transfer. Cloning Stem Cell 8, 283–293 (2006).

    Google Scholar 

38. Estrada, J. L. et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes. Xenotransplantation 22, 194–202 (2015).

    Google Scholar 

39. Li, P. et al. Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. Xenotransplantation 22, 20–31 (2015).

    Google Scholar 

40. Yang, L. et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science 350, 1101–1104 (2015). This is the first report of knocking out porcine endogenous retroviruses using CRISPR–Cas9 genetic engineering technology, addressing a major barrier to safe xenotransplantation.

    Google Scholar 

41. Ludwiczak, A. et al. How housing conditions determine the welfare of pigs. Animals 11, 3484 (2021).

    Google Scholar 

42. Pabst, R. The pig as a model for immunology research. Cell Tissue Res. 380, 287–304 (2020).

    Google Scholar 

43. Hinrichs, A. et al. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation 28, e12664 (2020).

    Google Scholar 

44. Hinrichs, A. et al. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver. Mol. Metab. 11, 113–128 (2018).

    Google Scholar 

45. Unger, E. Nierentransplantationen. Klin. Wschr. 47, 573 (1910).

    Google Scholar 

46. Lexer, G. et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J. Heart Transpl. 5, 411–418 (1986).

    Google Scholar 

47. Lin, S. S. et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101, 1745–1756 (1998).

    Google Scholar 

48. Cooper, D. K. C., Koren, E. & Oriol, R. Genetically engineered pigs. Lancet 342, 682–683 (1993).

    Google Scholar 

49. Byrne, G., Ahmad-Villiers, S., Du, Z. & McGregor, C. B4GALNT2 and xenotransplantation: a newly appreciated xenogeneic antigen. Xenotransplantation 25, e12394 (2018).

    Google Scholar 

50. Gao, B. et al. Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans. PLoS ONE 12, e0180768 (2017).

    Google Scholar 

51. Singireddy, S. et al. Genetic engineering of donor pig for the first human cardiac xenotransplantation: combatting rejection, coagulopathy, inflammation, and excessive growth. Curr. Cardiol. Rep. 25, 1649–1656 (2023).

    Google Scholar 

52. Freeley, S., Kemper, C. & Le Friec, G. The “ins and outs” of complement-driven immune responses. Immunol. Rev. 274, 16–32 (2016).

    Google Scholar 

53. Dalmasso, A. P. et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140, 1157–1166 (1992).

    Google Scholar 

54. Fodor, W. L. et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl Acad. Sci. USA 91, 11153–11157 (1994).

    Google Scholar 

55. RosENGARD, A. M. et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. Transplantation 59, 1325 (1995).

    Google Scholar 

56. Stern, D. M. et al. Endothelium and regulation of coagulation. Diabetes Care 14, 160–166 (1991).

    Google Scholar 

57. Yau, J. W., Teoh, H. & Verma, S. Endothelial cell control of thrombosis. BMC Cardiovasc. Disord. 15, 130 (2015).

    Google Scholar 

58. Fischetti, F. & Tedesco, F. Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity 39, 417–428 (2006).

    Google Scholar 

59. Aghajanian, A., Wittchen, E. S., Allingham, M. J., Garrett, T. A. & Burridge, K. Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration. J. Thromb. Haemost. 6, 1453–1460 (2008).

    Google Scholar 

60. Vanhove, B., Bach, F.H. Human xenoreactive natural antibodies–avidity and targets on porcine endothelial cells. Transplantation 56, 1251–1253 (1993).

    Google Scholar 

61. Candinas, D. et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 62, 1920–1927 (1996).

    Google Scholar 

62. Qin, G., Sjoberg, T., Liao, Q., Sun, X. & Steen, S. Intact endothelial and contractile function of coronary artery after 8 h of heart preservation. Scand. Cardiovasc. J. 50, 362–366 (2016).

    Google Scholar 

63. Cooper, D. K. C., Kemp, E., Platt, J. L. & White, D. J. G. (eds) Xenotransplantation: The Transplantation of Organs and Tissues Between Species 2nd edn (Springer, 2012).

64. Sfriso, R. et al. Assessment of the anticoagulant and anti-inflammatory properties of endothelial cells using 3D Cell culture and non-anticoagulated whole blood. J. Vis. Exp. https://doi.org/10.3791/56227 (2017).

    Article  Google Scholar 

65. Sfriso, R. et al. 3D artificial round section micro-vessels to investigate endothelial cells under physiological flow conditions. Sci. Rep. 8, 5898 (2018).

    Google Scholar 

66. Rataj, D. et al. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation. Xenotransplantation 23, 117–127 (2016).

    Google Scholar 

67. Tran, T. et al. Assessment of NK cytotoxicity and interactions with porcine endothelial cells by live-cell imaging in 2D static and 3D microfluidic systems. Sci. Rep. 14, 24199 (2024).

    Google Scholar 

68. Beckman, J. D. et al. JAK–STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions. J. Thromb. Haemost. 21, 1366–1380 (2023).

    Google Scholar 

69. Liu, H., Gan, Z., Qin, X., Wang, Y. & Qin, J. Advances in microfluidic technologies in organoid research. Adv. Healthc. Mater. 13, e2302686 (2024).

    Google Scholar 

70. Dorling, A., Lombardi, G., Binns, R. & Lechler, R. I. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur. J. Immunol. 26, 1378–1387 (1996).

    Google Scholar 

71. Yamada, K., Sachs, D. H. & DerSimonian, H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J. Immunol. 155, 5249–5256 (1995).

    Google Scholar 

72. Tomasi, R. et al. T-cell response in a cardiac xenotransplant model. Exp. Clin. Transpl. 19, 708–716 (2021).

    Google Scholar 

73. Mohiuddin, M. M. et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat. Commun. 7, 11138 (2016). This article reports the longest genetically engineered porcine cardiac xenograft survival in non-human primates, highlighting the importance of immunosuppressive strategies.

    Google Scholar 

74. Kuwaki, K. et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11, 29–31 (2005).

    Google Scholar 

75. Iwase, H. et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date. Xenotransplantation 22, 302–309 (2015).

    Google Scholar 

76. Mohiuddin, M. M. et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet https://doi.org/10.1016/S0140-6736(23)00775-4 (2023).

    Article  Google Scholar 

77. Mohiuddin, M. M. et al. Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months. Xenotransplantation 29, e12744 (2022). This article reports the longest life-supporting genetically engineered porcine cardiac xenograft survival in non-human primates, achieving up to 9 months.

    Google Scholar 

78. Iwase, H. et al. Pig-to-baboon heterotopic heart transplantation-exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 22, 211–220 (2015).

    Google Scholar 

79. Chaban, R. et al. Enhanced costimulation blockade with αCD154, αCD2, and αCD28 to promote heart allograft tolerance in nonhuman primates. Transplantation https://doi.org/10.1097/TP.0000000000005315 (2025).

    Article  Google Scholar 

80. Singh, A. K. et al. Genetically engineered pig heart transplantation in non-human primates. Commun. Med. 5, 6 (2025).

    Google Scholar 

81. Kim, S. C. et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion. Am. J. Transplant. 19, 2174–2185 (2019).

    Google Scholar 

82. Zhang, W. et al. Genetically engineered pig-to-human liver xenotransplantation. J. Hepatol. https://doi.org/10.1016/j.jhep.2025.08.044 (2025).

    Article  Google Scholar 

83. Lai, L. et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295, 1089–1092 (2002).

    Google Scholar 

84. Fischer, K. et al. Efficient production of multi-modified pigs for xenotransplantation by ‘combineering’, gene stacking and gene editing. Sci. Rep. 6, 29081 (2016).

    Google Scholar 

85. Janeway, C. A. Immunobiology: The Immune System in Health and Disease 5th edn (Garland, 2001).

86. Singh, A. K. et al. CD40–CD40L blockade: update on novel investigational therapeutics for transplantation. Transplantation https://doi.org/10.1097/TP.0000000000004469 (2022).

    Article  Google Scholar 

87. Elgueta, R. et al. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229, 152–172 (2009).

    Google Scholar 

88. Bolduc, A. et al. Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas. J. Immunol. 185, 220–230 (2010).

    Google Scholar 

89. Callard, R. E., Herbert, J., Smith, S. H., Armitage, R. J. & Costelloe, K. E. CD40 cross-linking inhibits specific antibody production by human B cells. Int. Immunol. 7, 1809–1815 (1995).

    Google Scholar 

90. Todd, J. L. & Palmer, S. M. Danger signals in regulating the immune response to solid organ transplantation. J. Clin. Invest. 127, 2464–2472 (2017).

    Google Scholar 

91. Land, W. G., Agostinis, P., Gasser, S., Garg, A. D. & Linkermann, A. Transplantation and damage-associated molecular patterns (DAMPs). Am. J. Transplant. 16, 3338–3361 (2016).

    Google Scholar 

92. Langin, M. et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 564, 430–433 (2018).

    Google Scholar 

93. Goerlich, C. E. et al. Blood cardioplegia induction, perfusion storage and graft dysfunction in cardiac xenotransplantation. Front. Immunol. 12, 667093 (2021).

    Google Scholar 

94. Langin, M. et al. Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation. Xenotransplantation 28, e12636 (2021).

    Google Scholar 

95. Cleveland, D. C. The genetically engineered heart as a bridge to allotransplantation in infants just around the corner? Ann. Thorac. Surg. 114, 536–544 (2022).

    Google Scholar 

96. Mitchell, C. B. Early results of an infant model of orthotopic cardiac xenotransplantation. J. Heart Lung Transplant. 44, 503–510 (2025).

    Google Scholar 

97. Jackson, A. M. et al. Endothelial cell antibodies associated with novel targets and increased rejection. J. Am. Soc. Nephrol. 26, 1161–1171 (2015).

    Google Scholar 

98. Xu-Dubois, Y. C. et al. Markers of endothelial-to-mesenchymal transition: evidence for antibody–endothelium interaction during antibody-mediated rejection in kidney recipients. J. Am. Soc. Nephrol. 27, 324–332 (2016).

    Google Scholar 

99. Li, P. et al. Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses. Sci. Rep. 11, 13131 (2021).

    Google Scholar 

100. Loupy, A. et al. Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study. Lancet 402, 1158–1169 (2023).

     Google Scholar 

101. Montgomery, R. A., Griesemer, A. D., Segev, D. L. & Sommer, P. The decedent model: a new paradigm for de-risking high stakes clinical trials like xenotransplantation. Am. J. Transplant. 24, 526–532 (2024).

     Google Scholar 

102. Brenner, P. et al. IG-therasorb immunoapheresis in orthotopic xenotransplantation of baboons with landrace pig hearts. Transplantation 69, 208–214 (2000).

     Google Scholar 

103. Knechtle, S. Is allosensitization detrimental to pig organ xenotransplantation, and is xenosensitization detrimental to subsequent organ allotransplantation? A debate organized by the International Xenotransplantation Association (IXA). Xenotransplantation 31, 12884 (2024).

     Google Scholar 

104. Tector, A. J., Adams, A. B. & Tector, M. Current status of renal xenotransplantation and next steps. Kidney360 4, 278–284 (2023).

     Google Scholar 

105. Mohiuddin, M. M. et al. B cell depletion along with co-stimulation blockade by anti CD40 (clone 2C10) extends graft survival significantly in a heterotopic cardiac xenotransplantation model. Transplantation 94, 70–70 (2012).

     Google Scholar 

106. Anand, R. P. et al. Design and testing of a humanized porcine donor for xenotransplantation. Nature 622, 393–401 (2023).

     Google Scholar 

107. Julier, Z., Park, A. J., Briquez, P. S. & Martino, M. M. Promoting tissue regeneration by modulating the immune system. Acta Biomater. 53, 13–28 (2017).

     Google Scholar 

108. Leventhal, J. et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci. Transl. Med. 4, 124ra128 (2012).

     Google Scholar 

109. Fitch, Z. W. et al. Introducing thymus for promoting transplantation tolerance. J. Allergy Clin. Immunol. 150, 549–556 (2022).

     Google Scholar 

110. Theil, A. et al. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. Cytotherapy 17, 473–486 (2015).

     Google Scholar 

111. Slomovich, S. Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment. Clin. Transplant. 35, 14333 (2021).

     Google Scholar 

112. Takasato, F. et al. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells. PLoS ONE 9, e87722 (2014).

     Google Scholar 

113. Leventhal, J. R. Evaluation of immunocompetence and biomarkers of tolerance in chimeric and immunosuppression-free kidney allograft recipients. Transplantation 107, 257–268 (2023).

     Google Scholar 

114. Mathew, J. M. A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants. Sci. Rep. 8, 7428–7427 (2018).

     Google Scholar 

115. Kologrivova, I., Shtatolkina, M., Suslova, T. & Ryabov, V. Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front. Immunol. 12, 664457 (2021).

     Google Scholar 

116. Langin, M. et al. Xenografts show signs of concentric hypertrophy and dynamic left ventricular outflow tract obstruction after orthotopic pig-to-baboon heart transplant. Transplantation 107, e328–e338 (2023).

     Google Scholar 

117. Shah, A. Anatomical differences between human and pig hearts and their relevance for cardiac xenotransplantation surgical technique. JACC Case Rep. 4, 1049–1052 (2022).

     Google Scholar 

118. Carrier, A. N. Xenotransplantation: a new era. Front. Immunol. 13, 900594 (2022).

     Google Scholar 

119. Matsumoto, S. & Matsumoto, K. clinical islet xenotransplantation: development of isolation protocol, anti-rejection strategies, and clinical outcomes. Cells https://doi.org/10.3390/cells13100828 (2024).

120. Cayabyab, F., Nih, L. R. & Yoshihara, E. Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front. Endocrinol. 12, 732431 (2021).

     Google Scholar 

121. van der Windt, D. J., Echeverri, G. J., Ijzermans, J. N. & Cooper, D. K. The choice of anatomical site for islet transplantation. Cell Transpl. 17, 1005–1014 (2008).

     Google Scholar 

122. Liu, S. S. et al. Encapsulated islet transplantation. Nat. Rev. Bioeng. 3, 83–102 (2025).

     Google Scholar 

123. Cooper, D. K. C., Mou, L. & Bottino, R. A brief review of the current status of pig islet xenotransplantation. Front. Immunol. 15, 1366530 (2024).

     Google Scholar 

124. Chan, J. C. Y. Future of lung transplantation: xenotransplantation and bioengineering lungs. Clin. Chest Med. 44, 201–214 (2023).

     Google Scholar 

125. Burdorf, L. et al. Pig-to-baboon lung xenotransplantation: extended survival with targeted genetic modifications and pharmacologic treatments. Am. J. Transplant. 22, 28–45 (2022).

     Google Scholar 

126. DeLaura, I. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model. Xenotransplantation 31, 12833 (2024).

     Google Scholar 

127. Shah, P. Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. J. Heart Lung Transplant. 41, 1401–1413 (2022).

     Google Scholar 

128. Nog, R., Aggarwal Gupta, C. & Panza, J. A. Role of MicroRNA in heart transplant. Cardiol. Rev. 30, 253–257 (2022).

     Google Scholar 

129. Sun, J. P. et al. Non-invasive evaluation of orthotopic heart transplant rejection by echocardiography. J. Heart Lung Transpl. 24, 160–165 (2005).

     Google Scholar 

130. Tseng, A. S. et al. Use of speckle-tracking echocardiography-derived strain and systolic strain rate measurements to predict rejection in transplant hearts with preserved ejection fraction. BMC Cardiovasc. Disord. 18, 241 (2018).

     Google Scholar 

131. Kekatos, M. Woman is 1st patient to undergo combined heart pump implant and pig kidney transplant. ABC7News https://abc7news.com/post/woman-from-nj-is-1st-patient-to-undergo-combined-heart-pump-implant-and-pig-kidney-transplant-at-nyu-langone/14726555/ (24 April 2024).

132. Mallapaty, S. First pig liver transplanted into a person lasts for 10 days. Nature 627, 710–711 (2024).

     Google Scholar 

133. Jaboulay, M. Greffe de reins au pli du coude par soudures artérielles et veineuses. Lyon Méd. 107, 575–577 (1906).

     Google Scholar 

134. Neuhof, H. Transplantation of Tissues (Appleton, 1923).

135. Brunet, J. P. Xeno-transplantation in humans. Med. Rep. Case Stud. 8, 01–11 (2023).

     Google Scholar 

136. Reemtsma, K., McCracken, B. H., Schlegel, J. U. & Pearl, M. Heterotransplantation of the kidney: two clinical experiences. Science 143, 700–702 (1964).

     Google Scholar 

137. Dureau, Fradin, Gonin, Michaud & Mikaeloff. [Heart and liver transplantations]. Lyon Med. 222, 585–586 (1969).

     Google Scholar 

138. Czaplicki, J., Blonska, B. & Religa, Z. The lack of hyperacute xenogeneic heart transplant rejection in a human. J. Heart Lung Transpl. 11, 393–397 (1992).

     Google Scholar 

139. Bailey, L. L., Nehlsen-Cannarella, S. L., Concepcion, W. & Jolley, W. B. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 254, 3321–3329 (1985).

     Google Scholar 

140. Giles, G. R., Boehmig, H. J., Amemiya, H., Halgrimson, C. G. & Starzl, T. E. Clinical heterotransplantation of the liver. Transpl. Proc. 2, 506–512 (1970).

     Google Scholar 

141. Starzl, T. E. et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transpl. Proc. 6, 129–139 (1974).

     Google Scholar 

142. Leger, L., Chapuis, Y., Lenriot, J. P. & Deloche, A. [Heterotopic transplantation of a baboon liver to man]. Presse Med. 78, 429–430 (1970).

     Google Scholar 

143. Pouyet, M. & Berard, P. [2 Cases of true heterotopic transplantation of the baboon liver in malignant acute hepatitis]. Lyon Chir. 67, 288–291 (1971).

     Google Scholar 

144. Makowa, L. et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59, 1654–1659 (1995).

     Google Scholar 

145. Montgomery, R. In a first, surgeons attached a pig kidney to a human, and it worked. The New york Times (21 October 2021).

146. Locke, J. E., Kumar, V., Anderson, D. & Porrett, P. M. Normal graft function after pig-to-human kidney xenotransplant. JAMA Surg. 158, 1106–1108 (2023).

     Google Scholar 

147. Moazami, N. et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat. Med. 29, 1989–1997 (2023).

     Google Scholar 

148. He, J. et al. Pig-to-human lung xenotransplantation into a brain-dead recipient. Nat. Med. https://doi.org/10.1038/s41591-025-03861-x (2025).

     Article  Google Scholar 

149. Kozlov, M. Pig-organ transplants: what three human recipients have taught scientists. Nature 629, 980–981 (2024).

     Google Scholar 

150. Phelps, C. J. et al. Production of α1,3-galactosyltransferase-deficient pigs. Science 299, 411–414 (2003).

     Google Scholar 

151. Mohiuddin, M. M. et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am. J. Transplant. 12, 763–771 (2012).

     Google Scholar 

152. Burlak, C. et al. Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs. Am. J. Transplant. 14, 1895–1900 (2014).

     Google Scholar 

153. Butler, J. R. et al. Silencing porcine CMAH and GGTA1 genes significantly reduces xenogeneic consumption of human platelets by porcine livers. Transplantation 100, 571–576 (2016).

     Google Scholar 

154. Mohiuddin, M. M. et al. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J. Thorac. Cardiovasc. Surg. 148, 1106–1113 (2014).

     Google Scholar 

155. Mohiuddin, M. M. et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am. J. Transplant. 14, 488–489 (2014).

     Google Scholar 

156. Niu, D. et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR–Cas9. Science 357, 1303–1307 (2017).

     Google Scholar 

157. Martens, G. R. et al. Humoral reactivity of renal transplant-waitlisted patients to cells from GGTA1/CMAH/B4GalNT2, and SLA class I knockout pigs. Transplantation 101, e86–e92 (2017).

     Google Scholar 

158. Porrett, P. M. et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. Am. J. Transplant. 22, 1037–1053 (2022).

     Google Scholar 

159. Goerlich, C. E. et al. The immunobiology and clinical use of genetically engineered porcine hearts for cardiac xenotransplantation. Nat. Cardiovasc. Res. 1, 715–726 (2022).

     Google Scholar 

160. Gultom, M. & Rieben, R. Complement, coagulation, and fibrinolysis: the role of the endothelium and its glycocalyx layer in xenotransplantation. Transpl. Int. https://doi.org/10.3389/ti.2024.13473 (2024).

161. Hawthorne, W. J. et al. Third WHO Global Consultation on regulatory requirements for xenotransplantation clinical trials, Changsha, Hunan, China December 12–14, 2018: “the 2018 Changsha Communique” the 10-year anniversary of the international consultation on xenotransplantation. Xenotransplantation 26, e12513 (2019).

     Google Scholar 

162. Arcidiacono, J. A., Evdokimov, E. A. & Howard, H. J. in Xenotransplantation: Ethical, Regulatory, and Social Aspects (eds Hurst, D. J., Padilla, L. & Paris, W. D.) 107–119 (Springer, 2023).

163. Schuurman, H. J. in Xenotransplantation: Ethical, Regulatory, and Social Aspects (eds Hurst, D. J., Padilla, L. & Paris, W. D.) 121–140 (Springer, 2023).

164. Hurst, D. J. in Xenotransplantation: Ethical, Regulatory, and Social Aspects (eds Hurst, D. J., Padilla, L. & Paris, W. D.) 59–67 (Springer, 2023).

165. Rothblatt, M. in Xenotransplantation: Ethical, Regulatory, and Social Aspects (eds Hurst, D. J., Padilla, L. & Paris, W. D.) 69–74 (Springer, 2023).

166. Fishman, J. A. Risks of infectious disease in xenotransplantation. N. Engl. J. Med. 387, 2258–2267 (2022).

     Google Scholar 

167. Opriessnig, T. & Halbur, P. G. in Xenotransplantation: Ethical, Regulatory, and Social Aspects (eds Hurst, D. J., Padilla, L. & Paris, W. D.) 75–103 (Springer, 2023).

Download references